Activation of human colon mast cells through proteinase activated receptor-2
AIM:To investigate the ability of agonists of PAR-2 to stimulate release of tryptase and histamine from human colon mast cells and the potential mechanisms.METHODS:Enzymatically dispersed cells from human colons were challenged with tc-LIGRLO, tc-OLRGIL, SLIGKV,VKGILS, trypsin, anti-IgE or calcium i...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2004-02, Vol.10 (3), p.327-331 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 331 |
---|---|
container_issue | 3 |
container_start_page | 327 |
container_title | World journal of gastroenterology : WJG |
container_volume | 10 |
creator | He, Shao-Heng He, Yong-Song Xie, Hua |
description | AIM:To investigate the ability of agonists of PAR-2 to stimulate release of tryptase and histamine from human colon mast cells and the potential mechanisms.METHODS:Enzymatically dispersed cells from human colons were challenged with tc-LIGRLO, tc-OLRGIL, SLIGKV,VKGILS, trypsin, anti-IgE or calcium ionophore A23187,and the cell supematants after challenge were collected. Tryptase release was determined with a sandwich ELISA procedure and histamine release was measured using a glass fibrebased fluorometric assay.RESULTS: Both PAR-2 agonists tc-LIGRLO-NH2 and SLIGKVNH2 were able to induce dose dependent release of tryptase and histamine from colon mast cells. More than 2.5 fold increase in both tryptase and histamine release was provoked by 100μmol/mL tc-LIGRLO-NH2, in comparison with only 2.0 fold increase being stimulated by SLIGKV-NH2,The reverse peptides tc-OLRGIL-NH2 and VKGILS-NH2 at the concentrations tested had no effect on the release of these two mediators.The maximum tryptase release elicited by tc-LIGRLO-NH2 was similar to that induced by anti-IgE(10μg/mL) or calcium ionophore (1μg/mL), though the latter was a more potent stimulus for histamine release.Both histamine and tryptase release in response to tc-LIGRLONH2 were completed within 3 rain. Trypsin at concentrations from 1.0 to 100μg/mL was capable of provoking a dose dependent release of tryptase as well as histamine with a maximum of 16ng/mL tryptase and 14ng/mL histamine release being achieved. An approximately 80% and 70% inhibition of trypsin induced release of tryptase and histamine were observed with SBTI, respectively. Pretreatment of cells with metabolic inhibitors or pertussis toxin abolished the actions of tc-LIGRLO-NH2, SLIGKV-NH2 and trypsin.CONCLUSION: The agonists of PAR-2 and trypsin are potent secretagogues of human colon mast cells, which are likely to contribute to the development of inflammatory disorders in human gut. |
doi_str_mv | 10.3748/wjg.v10.i3.327 |
format | Article |
fullrecord | <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4724906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>9648983</cqvip_id><wanfj_id>wjg200403004</wanfj_id><sourcerecordid>wjg200403004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-ce8e57bdcd7ce5d099aa74e184c8e3d4a8babf885b453be256e0ab7386ffac1d3</originalsourceid><addsrcrecordid>eNpVkUuP0zAUhS0EYjoDW5YoSGh2KX4ldjZIoxEvqRIbWFs3zk3iktgdO-mIf49LKx4bW9c-9_PxPYS8YnQrlNTvHvfD9pgLJ7aCqydkwzlrSq4lfUo2jFJVNvn8ilyntKeUC1Hx5-SKSVVTVbEN2d3ZxR1hccEXoS_GdQZf2DDlcoa0FBanKRXLGMM6jMUhhgWdh4QFnPuwKyJaPCwhlvwFedbDlPDlZb8h3z9--Hb_udx9_fTl_m5XWinZUlrUWKm2s52yWHW0aQCURKal1Sg6CbqFtte6amUlWuRVjRRaJXTd92BZJ27I-zP3sLYzdhb9EmEyh-hmiD9NAGf-v_FuNEM4Gqm4bGidAW_PgEfwPfjB7MMafbZs8jw5pZKKvGTZ7eWdGB5WTIuZXTpNBDyGNRlNmeT1b972LLQxpBSx_-OFUXPK6cQ1OSfjhMl55IbX__7gr_wSTBa8uRDH4IcHlz22YH_0bkLT1FI3Wohf57ydGw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80142606</pqid></control><display><type>article</type><title>Activation of human colon mast cells through proteinase activated receptor-2</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>He, Shao-Heng ; He, Yong-Song ; Xie, Hua</creator><creatorcontrib>He, Shao-Heng ; He, Yong-Song ; Xie, Hua</creatorcontrib><description>AIM:To investigate the ability of agonists of PAR-2 to stimulate release of tryptase and histamine from human colon mast cells and the potential mechanisms.METHODS:Enzymatically dispersed cells from human colons were challenged with tc-LIGRLO, tc-OLRGIL, SLIGKV,VKGILS, trypsin, anti-IgE or calcium ionophore A23187,and the cell supematants after challenge were collected. Tryptase release was determined with a sandwich ELISA procedure and histamine release was measured using a glass fibrebased fluorometric assay.RESULTS: Both PAR-2 agonists tc-LIGRLO-NH2 and SLIGKVNH2 were able to induce dose dependent release of tryptase and histamine from colon mast cells. More than 2.5 fold increase in both tryptase and histamine release was provoked by 100μmol/mL tc-LIGRLO-NH2, in comparison with only 2.0 fold increase being stimulated by SLIGKV-NH2,The reverse peptides tc-OLRGIL-NH2 and VKGILS-NH2 at the concentrations tested had no effect on the release of these two mediators.The maximum tryptase release elicited by tc-LIGRLO-NH2 was similar to that induced by anti-IgE(10μg/mL) or calcium ionophore (1μg/mL), though the latter was a more potent stimulus for histamine release.Both histamine and tryptase release in response to tc-LIGRLONH2 were completed within 3 rain. Trypsin at concentrations from 1.0 to 100μg/mL was capable of provoking a dose dependent release of tryptase as well as histamine with a maximum of 16ng/mL tryptase and 14ng/mL histamine release being achieved. An approximately 80% and 70% inhibition of trypsin induced release of tryptase and histamine were observed with SBTI, respectively. Pretreatment of cells with metabolic inhibitors or pertussis toxin abolished the actions of tc-LIGRLO-NH2, SLIGKV-NH2 and trypsin.CONCLUSION: The agonists of PAR-2 and trypsin are potent secretagogues of human colon mast cells, which are likely to contribute to the development of inflammatory disorders in human gut.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v10.i3.327</identifier><identifier>PMID: 14760751</identifier><language>eng</language><publisher>United States: Immunopharmacology Group,University of Southampton, Southampton, UK%Immunopharmacology Group,University of Southampton, Southampton, UK%Allergy and Inflammation Research Institute, Shantou University Medical College, Shantou 515031,Guangdong Province, China</publisher><subject>Colectomy ; Colon - cytology ; Colon - metabolism ; ELISA ; Humans ; Mast Cell And Inflammatory Bowel Disease ; Mast Cells - metabolism ; Receptor, PAR-2 - metabolism ; 类胰蛋白酶 ; 细胞激活 ; 肥大细胞 ; 蛋白激酶受体-2</subject><ispartof>World journal of gastroenterology : WJG, 2004-02, Vol.10 (3), p.327-331</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved. 2004</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-ce8e57bdcd7ce5d099aa74e184c8e3d4a8babf885b453be256e0ab7386ffac1d3</citedby><cites>FETCH-LOGICAL-c441t-ce8e57bdcd7ce5d099aa74e184c8e3d4a8babf885b453be256e0ab7386ffac1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724906/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724906/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14760751$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Shao-Heng</creatorcontrib><creatorcontrib>He, Yong-Song</creatorcontrib><creatorcontrib>Xie, Hua</creatorcontrib><title>Activation of human colon mast cells through proteinase activated receptor-2</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM:To investigate the ability of agonists of PAR-2 to stimulate release of tryptase and histamine from human colon mast cells and the potential mechanisms.METHODS:Enzymatically dispersed cells from human colons were challenged with tc-LIGRLO, tc-OLRGIL, SLIGKV,VKGILS, trypsin, anti-IgE or calcium ionophore A23187,and the cell supematants after challenge were collected. Tryptase release was determined with a sandwich ELISA procedure and histamine release was measured using a glass fibrebased fluorometric assay.RESULTS: Both PAR-2 agonists tc-LIGRLO-NH2 and SLIGKVNH2 were able to induce dose dependent release of tryptase and histamine from colon mast cells. More than 2.5 fold increase in both tryptase and histamine release was provoked by 100μmol/mL tc-LIGRLO-NH2, in comparison with only 2.0 fold increase being stimulated by SLIGKV-NH2,The reverse peptides tc-OLRGIL-NH2 and VKGILS-NH2 at the concentrations tested had no effect on the release of these two mediators.The maximum tryptase release elicited by tc-LIGRLO-NH2 was similar to that induced by anti-IgE(10μg/mL) or calcium ionophore (1μg/mL), though the latter was a more potent stimulus for histamine release.Both histamine and tryptase release in response to tc-LIGRLONH2 were completed within 3 rain. Trypsin at concentrations from 1.0 to 100μg/mL was capable of provoking a dose dependent release of tryptase as well as histamine with a maximum of 16ng/mL tryptase and 14ng/mL histamine release being achieved. An approximately 80% and 70% inhibition of trypsin induced release of tryptase and histamine were observed with SBTI, respectively. Pretreatment of cells with metabolic inhibitors or pertussis toxin abolished the actions of tc-LIGRLO-NH2, SLIGKV-NH2 and trypsin.CONCLUSION: The agonists of PAR-2 and trypsin are potent secretagogues of human colon mast cells, which are likely to contribute to the development of inflammatory disorders in human gut.</description><subject>Colectomy</subject><subject>Colon - cytology</subject><subject>Colon - metabolism</subject><subject>ELISA</subject><subject>Humans</subject><subject>Mast Cell And Inflammatory Bowel Disease</subject><subject>Mast Cells - metabolism</subject><subject>Receptor, PAR-2 - metabolism</subject><subject>类胰蛋白酶</subject><subject>细胞激活</subject><subject>肥大细胞</subject><subject>蛋白激酶受体-2</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkUuP0zAUhS0EYjoDW5YoSGh2KX4ldjZIoxEvqRIbWFs3zk3iktgdO-mIf49LKx4bW9c-9_PxPYS8YnQrlNTvHvfD9pgLJ7aCqydkwzlrSq4lfUo2jFJVNvn8ilyntKeUC1Hx5-SKSVVTVbEN2d3ZxR1hccEXoS_GdQZf2DDlcoa0FBanKRXLGMM6jMUhhgWdh4QFnPuwKyJaPCwhlvwFedbDlPDlZb8h3z9--Hb_udx9_fTl_m5XWinZUlrUWKm2s52yWHW0aQCURKal1Sg6CbqFtte6amUlWuRVjRRaJXTd92BZJ27I-zP3sLYzdhb9EmEyh-hmiD9NAGf-v_FuNEM4Gqm4bGidAW_PgEfwPfjB7MMafbZs8jw5pZKKvGTZ7eWdGB5WTIuZXTpNBDyGNRlNmeT1b972LLQxpBSx_-OFUXPK6cQ1OSfjhMl55IbX__7gr_wSTBa8uRDH4IcHlz22YH_0bkLT1FI3Wohf57ydGw</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>He, Shao-Heng</creator><creator>He, Yong-Song</creator><creator>Xie, Hua</creator><general>Immunopharmacology Group,University of Southampton, Southampton, UK%Immunopharmacology Group,University of Southampton, Southampton, UK%Allergy and Inflammation Research Institute, Shantou University Medical College, Shantou 515031,Guangdong Province, China</general><general>Allergy and Inflammation Research Institute, Shantou University Medical College, Shantou 515031,Guangdong Province, China</general><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20040201</creationdate><title>Activation of human colon mast cells through proteinase activated receptor-2</title><author>He, Shao-Heng ; He, Yong-Song ; Xie, Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-ce8e57bdcd7ce5d099aa74e184c8e3d4a8babf885b453be256e0ab7386ffac1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Colectomy</topic><topic>Colon - cytology</topic><topic>Colon - metabolism</topic><topic>ELISA</topic><topic>Humans</topic><topic>Mast Cell And Inflammatory Bowel Disease</topic><topic>Mast Cells - metabolism</topic><topic>Receptor, PAR-2 - metabolism</topic><topic>类胰蛋白酶</topic><topic>细胞激活</topic><topic>肥大细胞</topic><topic>蛋白激酶受体-2</topic><toplevel>online_resources</toplevel><creatorcontrib>He, Shao-Heng</creatorcontrib><creatorcontrib>He, Yong-Song</creatorcontrib><creatorcontrib>Xie, Hua</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Shao-Heng</au><au>He, Yong-Song</au><au>Xie, Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of human colon mast cells through proteinase activated receptor-2</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2004-02-01</date><risdate>2004</risdate><volume>10</volume><issue>3</issue><spage>327</spage><epage>331</epage><pages>327-331</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM:To investigate the ability of agonists of PAR-2 to stimulate release of tryptase and histamine from human colon mast cells and the potential mechanisms.METHODS:Enzymatically dispersed cells from human colons were challenged with tc-LIGRLO, tc-OLRGIL, SLIGKV,VKGILS, trypsin, anti-IgE or calcium ionophore A23187,and the cell supematants after challenge were collected. Tryptase release was determined with a sandwich ELISA procedure and histamine release was measured using a glass fibrebased fluorometric assay.RESULTS: Both PAR-2 agonists tc-LIGRLO-NH2 and SLIGKVNH2 were able to induce dose dependent release of tryptase and histamine from colon mast cells. More than 2.5 fold increase in both tryptase and histamine release was provoked by 100μmol/mL tc-LIGRLO-NH2, in comparison with only 2.0 fold increase being stimulated by SLIGKV-NH2,The reverse peptides tc-OLRGIL-NH2 and VKGILS-NH2 at the concentrations tested had no effect on the release of these two mediators.The maximum tryptase release elicited by tc-LIGRLO-NH2 was similar to that induced by anti-IgE(10μg/mL) or calcium ionophore (1μg/mL), though the latter was a more potent stimulus for histamine release.Both histamine and tryptase release in response to tc-LIGRLONH2 were completed within 3 rain. Trypsin at concentrations from 1.0 to 100μg/mL was capable of provoking a dose dependent release of tryptase as well as histamine with a maximum of 16ng/mL tryptase and 14ng/mL histamine release being achieved. An approximately 80% and 70% inhibition of trypsin induced release of tryptase and histamine were observed with SBTI, respectively. Pretreatment of cells with metabolic inhibitors or pertussis toxin abolished the actions of tc-LIGRLO-NH2, SLIGKV-NH2 and trypsin.CONCLUSION: The agonists of PAR-2 and trypsin are potent secretagogues of human colon mast cells, which are likely to contribute to the development of inflammatory disorders in human gut.</abstract><cop>United States</cop><pub>Immunopharmacology Group,University of Southampton, Southampton, UK%Immunopharmacology Group,University of Southampton, Southampton, UK%Allergy and Inflammation Research Institute, Shantou University Medical College, Shantou 515031,Guangdong Province, China</pub><pmid>14760751</pmid><doi>10.3748/wjg.v10.i3.327</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2004-02, Vol.10 (3), p.327-331 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4724906 |
source | MEDLINE; PubMed Central; Alma/SFX Local Collection |
subjects | Colectomy Colon - cytology Colon - metabolism ELISA Humans Mast Cell And Inflammatory Bowel Disease Mast Cells - metabolism Receptor, PAR-2 - metabolism 类胰蛋白酶 细胞激活 肥大细胞 蛋白激酶受体-2 |
title | Activation of human colon mast cells through proteinase activated receptor-2 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T06%3A57%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20human%20colon%20mast%20cells%20through%20proteinase%20activated%20receptor-2&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=He,%20Shao-Heng&rft.date=2004-02-01&rft.volume=10&rft.issue=3&rft.spage=327&rft.epage=331&rft.pages=327-331&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v10.i3.327&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200403004%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80142606&rft_id=info:pmid/14760751&rft_cqvip_id=9648983&rft_wanfj_id=wjg200403004&rfr_iscdi=true |